Critical components of the SE complex, namely, BRD4, cyclin-dependent kinase 7 (CDK7) and MED1, are frequently overexpressed in HCC patients and are closely associated with a poor prognosis (Tsang et al., 2019). Here, BRD4 is linked to hepatocellular carcinoma.